pharma · Triple-Negative Breast Cancer (TNBC) · TELO
Telomir Pharmaceuticals
Telomir Pharmaceuticals patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Tampa, USA HQ
2022 Founded
6 Employees
Public company Type
TELO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tampa, USA
- Founded
- 2022
- Employees
- 6
- Programs
- 1
- Drugs
- 0
- Patents
- 0
Telomir Pharmaceuticals patents
0 pharmaceutical patents indexed for Telomir Pharmaceuticals. 0 expire within 24 months.
Telomir Pharmaceuticals has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Telomir Pharmaceuticals have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Telomir Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.